THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
Steven Shavell and A. Mitchell Polinsky

Vioxx verdict's dark side

By Steven Shavell and A. Mitchell Polinsky
August 23, 2005

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

A TEXAS JURY's Texas-size message to the drug manufacturer Merck last week may mean more than meets the eye. The jury awarded a $24 million base amount for the death of Robert Ernst and $229 million in punitive damages, apparently for Merck's failure to adequately disclose the risk of heart problems from Vioxx. Merck's stock market value declined by $5 ... (Full article: 660 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass